Latest News about Dea
Recent news which mentions Dea
Exclusive: BioHarvest Partners With DEA-Licensed Cannabis Grower To Supply Marijuana Products To Research Institutions
November 16, 2022
From Benzinga
3 Safe Dividend Stocks to Beat Inflation
November 10, 2022
From Motley Fool
4 Analysts Have This to Say About Easterly Government Props
November 03, 2022
Tickers
DEA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
From Benzinga
3 Top Dividend Stocks to Buy and Hold in 2023
October 25, 2022
From Motley Fool
3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
October 22, 2022
From Motley Fool
3 Attractive REITs With A Dividend Yield Over 6%
October 13, 2022
From Benzinga
3 Ridiculously Cheap High-Yield Dividend Stocks
October 12, 2022
From Motley Fool
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
October 04, 2022
From Benzinga
DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
September 29, 2022
Tickers
DEA
From Benzinga
Congressional Psychedelics Talks: Comments By Officials In Favor, Including Rep. Blumenauer And AOC
September 22, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Easterly Government Props
September 14, 2022
Tickers
DEA
From Benzinga
3 High-Yield Dividend Stocks to Buy in September Without Any Hesitation
September 03, 2022
From Motley Fool
Fetterman Calls On Biden To Decriminalize Cannabis, But White House Defers To States
August 30, 2022
Tickers
DEA
From Benzinga
From MarketWatch
DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
August 23, 2022
Tickers
DEA
From Benzinga
CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
August 18, 2022
From Benzinga
Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
August 17, 2022
From Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
From Benzinga
3 Dividend Stocks to Buy Right Now Without Any Hesitation
August 14, 2022
From Motley Fool
Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023
August 01, 2022
Tickers
DEA
From Benzinga
3 High-Yield Dividend Stocks to Buy in August
August 01, 2022
From Motley Fool
DEA Reports Uptick In Marijuana-Related Seizures & Arrests: Why Is This Happening? NORML Has An Idea
June 16, 2022
Tickers
DEA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.